Literature DB >> 17626872

Biochemistry. PI3K charges ahead.

Jennifer Y Lee1, Jeffrey A Engelman, Lewis C Cantley.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17626872     DOI: 10.1126/science.1146073

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  19 in total

1.  Cooperative activation of PI3K by Ras and Rho family small GTPases.

Authors:  Hee Won Yang; Min-Gyoung Shin; Sangkyu Lee; Jeong-Rae Kim; Wei Sun Park; Kwang-Hyun Cho; Tobias Meyer; Won Do Heo
Journal:  Mol Cell       Date:  2012-06-07       Impact factor: 17.970

2.  A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.

Authors:  Pradip K Majumder; Chiara Grisanzio; Fionnuala O'Connell; Marc Barry; Joseph M Brito; Qing Xu; Isil Guney; Raanan Berger; Paula Herman; Rachel Bikoff; Giuseppe Fedele; Won-Ki Baek; Shunyou Wang; Katharine Ellwood-Yen; Hong Wu; Charles L Sawyers; Sabina Signoretti; William C Hahn; Massimo Loda; William R Sellers
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

Review 3.  Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  World J Virol       Date:  2012-12-12

4.  CD28 co-signaling in the adaptive immune response.

Authors:  Pavel Riha; Christopher E Rudd
Journal:  Self Nonself       Date:  2010-07-12

5.  Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domains.

Authors:  Jennifer Y Lee; Yu-Hsin Chiu; John Asara; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 6.  Emerging biomarkers in head and neck cancer in the era of genomics.

Authors:  Hyunseok Kang; Ana Kiess; Christine H Chung
Journal:  Nat Rev Clin Oncol       Date:  2014-11-18       Impact factor: 66.675

Review 7.  Alterations and molecular targeting of the GSK-3 regulator, PI3K, in head and neck cancer.

Authors:  Michelle J Lee; Nan Jin; Jennifer R Grandis; Daniel E Johnson
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-02-19       Impact factor: 4.739

8.  Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers.

Authors:  Chang Hoon Song; So Yeon Park; Keun-Yong Eom; Jee Hyun Kim; Sung-Won Kim; Jae Sung Kim; In Ah Kim
Journal:  Breast Cancer Res       Date:  2010-03-12       Impact factor: 6.466

9.  H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3.

Authors:  A Chakrabarty; B N Rexer; S E Wang; R S Cook; J A Engelman; C L Arteaga
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

Review 10.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.